Cholinesterase affects dynamic transduction properties from vagal stimulation to heart rate.
Recent investigations in our laboratory using a Gaussian white noise technique showed that the transfer function representing the dynamic properties of transduction from vagus nerve activity to heart rate had characteristics of a first-order low-pass filter. However, the physiological determinants of those characteristics remain to be elucidated. In this study, we stimulated the vagus nerve according to a Gaussian white noise pattern to estimate the transfer function from vagal stimulation to the heart rate response in anesthetized rabbits and examined how changes in acetylcholine kinetics affected the transfer function. We found that although increases in the mean frequency of vagal stimulation from 5 to 10 Hz did not change the characteristics of the transfer function, administration of neostigmine (30 microg . kg-1 . h-1 iv), a cholinesterase inhibitor, increased the dynamic gain from 8.19 +/- 3.66 to 11.7 +/- 4.88 beats . min-1 . Hz-1 (P < 0.05), decreased the corner frequency from 0.12 +/- 0.05 to 0.04 +/- 0.01 Hz (P < 0.01), and increased the lag time from 0.17 +/- 0.12 to 0.27 +/- 0.08 s (P < 0.05). These results suggest that the rate of acetylcholine degradation at the neuroeffector junction, rather than the amount of available acetylcholine, plays a key role in determining the dynamic properties of transduction from vagus nerve activity to heart rate.
Nakahara
T
T
Department of Cardiovascular Dynamics, The National Cardiovascular Center Research Institute, Suita, Osaka, Japan.
Kawada
T
T
Sugimachi
M
M
Miyano
H
H
Sato
T
T
Shishido
T
T
Yoshimura
R
R
Miyashita
H
H
Sunagawa
K
K
D000109:Acetylcholine / Q000502:physiology; D000110:Acetylcholinesterase / Q000378:metabolism; D000161:Acoustic Stimulation; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology*; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D004558:Electric Stimulation; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology*; D007262:Infusions, Intravenous; D009388:Neostigmine / Q000008:administration & dosage / Q000494:pharmacology*; D011817:Rabbits; D014630:Vagus Nerve / Q000502:physiology*
D002800:Cholinesterase Inhibitors; D009388:Neostigmine; D000110:Acetylcholinesterase; D000109:Acetylcholine